Começar
ABBVIE DRNABBVIE DRNABBVIE DRN

ABBVIE DRN

Sem negociações
Veja nos super gráficos
Visão geral Finanças Notícias Ideias Discussões Sinais técnicos Sazonais
Títulos

ABBV34 títulos

Abaixo está a lista de títulos corporativos ABBVIE DRN. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo
YTM %
Volume
Preço %
Cupom %
Data de vencimento
Montante em circulação
Valor de face
Valor mín. de denominação
Emissor
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6,57%600 K84,44%4,55%2035-03-15107,646 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,56%15 K79,63%4,85%2044-06-1565,232 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6,44%10 K79,20%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,31%5 K80,72%4,63%2042-10-0167,493 M USD1.000,00 USD2.000,00 USDActavis, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,71%50 K89,00%3,20%2029-11-2162,515 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,60%16,254 M98,07%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,54%089,07%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,53%156 K91,37%4,85%2044-06-151,008 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,52%15,452 M98,00%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,50%43 K90,94%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,50%085,80%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,49%100 K98,22%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,46%90 K90,75%4,75%2045-03-15827,091 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,44%200 K90,15%4,63%2042-10-01389,217 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,43%1,115 M87,53%4,40%2042-11-062,599 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,38%30,789 M83,12%4,25%2049-11-215,745 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,29%4,815 M86,71%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,25%091,57%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,21%443 K94,62%4,55%2035-03-151,681 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,20%094,24%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5,08%5,243 M99,80%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,89%9,636 M100,32%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4,76%099,06%3,80%2025-03-15130,225 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,76%7,353 M93,03%3,20%2029-11-215,437 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4,75%096,53%2,95%2026-11-219,245 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,74%12,58 M100,24%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,64%097,92%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,61%5,096 M100,41%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,58%7,825 M98,80%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,54%2,74 M96,93%2,95%2026-11-213,991 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,33%099,29%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,19%673 K99,61%3,80%2025-03-152,889 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3,78%095,69%2,63%2028-11-1572,107 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3,77%093,12%2,13%2029-06-0136,462 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,07%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,03%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,96%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,89%089,58%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,77%097,23%2,13%2029-06-01506,088 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,75%099,53%2,63%2028-11-15427,793 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,68%097,89%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2,63%2,569 M99,97%2,60%2024-11-213,739 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2,52%094,87%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,01%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1,63%0102,15%3,80%2025-03-151,268 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3,63%0106,34%2,60%2024-11-2110,86 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1.000,00 USD2.000,00 USDAbbVie, Inc.